IP Verse

Pharmaceutical Formulations Comprising 4 {(1r) 2 [(6 {2 [(2,6 Dichlorobenzyl)Oxy] Ethoxy}Hexyl)Amino] 1 Hydroxyethyl} 2 (Hydroxymethyl)Phenol - EP2400950

PATENT ANALYSIS

Patent Details

Grant Date
May 22, 2019
Company
GLAXO GROUP LIMITED
Oppositions

AERA A/S

ARVEN ILAC SANAYI VE TICARET A.S.

DEHNS LTD

GILL JENNINGS & EVERY LLP

HGF LIMITED

N.V. NEDERLANDSCH OCTROOIBUREAU

SANDOZ AG

TEVA UK LIMITED

More patents of Glaxo Group Limited

EP3578169

EP1907037

EP2005372

Want to monitor this patent?

Feel free to send us a message here and we will get back to you